Balduzzi A - Search Results

1

Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.

Torrisi R, Dellapasqua S, Ghisini R, Viale G, Veronesi P, Luini A, Intra M, Peruzzotti G, Rocca A, Balduzzi A, Cardillo A, Goldhirsch A, Colleoni M. Torrisi R, et al. Among authors: balduzzi a. Breast. 2008 Dec;17(6):654-60. doi: 10.1016/j.breast.2008.05.002. Epub 2008 Jul 1. Breast. 2008. PMID: 18595702

2

Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.

Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Peruzzotti G, Goldhirsch A, D'Alessandro C, Cinieri S, Preda L, Colleoni M. Orlando L, et al. Among authors: balduzzi a. Anticancer Drugs. 2006 Sep;17(8):961-7. doi: 10.1097/01.cad.0000224454.46824.fc. Anticancer Drugs. 2006. PMID: 16940806 Clinical Trial.

3

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.

Orlando L, Cardillo A, Ghisini R, Rocca A, Balduzzi A, Torrisi R, Peruzzotti G, Goldhirsch A, Pietri E, Colleoni M. Orlando L, et al. Among authors: balduzzi a. BMC Cancer. 2006 Sep 15;6:225. doi: 10.1186/1471-2407-6-225. BMC Cancer. 2006. PMID: 16978400 Free PMC article. Clinical Trial.

4

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

Torrisi R, Balduzzi A, Ghisini R, Rocca A, Bottiglieri L, Giovanardi F, Veronesi P, Luini A, Orlando L, Viale G, Goldhirsch A, Colleoni M. Torrisi R, et al. Among authors: balduzzi a. Cancer Chemother Pharmacol. 2008 Sep;62(4):667-72. doi: 10.1007/s00280-007-0652-z. Epub 2007 Dec 7. Cancer Chemother Pharmacol. 2008. PMID: 18064460 Clinical Trial.

5

Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.

Orlando L, Del Curto B, Gandini S, Ghisini R, Pietri E, Torrisi R, Balduzzi A, Cardillo A, Dellapasqua S, Veronesi P, Viale G, Goldhirsch A, Colleoni M. Orlando L, et al. Among authors: balduzzi a. Breast. 2008 Oct;17(5):506-11. doi: 10.1016/j.breast.2008.03.007. Epub 2008 May 5. Breast. 2008. PMID: 18456496 Free article.

6

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.

D'Alessandro C, Dellapasqua S, Orlando L, Santoro L, Maisonneuve P, Torrisi R, Balduzzi A, Scarano E, Ghisini R, Peruzzotti G, Goldhirsch A, Colleoni M. D'Alessandro C, et al. Among authors: balduzzi a. Breast J. 2008 Sep-Oct;14(5):435-41. doi: 10.1111/j.1524-4741.2008.00619.x. Breast J. 2008. PMID: 18821931

7

Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.

Balduzzi A, Montagna E, Bagnardi V, Torrisi R, Bertolini F, Mancuso P, Scarano E, Viale G, Veronesi P, Cardillo A, Orlando L, Goldhirsch A, Colleoni M. Balduzzi A, et al. Anticancer Drugs. 2009 Mar;20(3):197-203. doi: 10.1097/CAD.0b013e3283264719. Anticancer Drugs. 2009. PMID: 19182679

8

Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer.

Iorfida M, Bagnardi V, Balduzzi A, Dellapasqua S, Cardillo A, Luini A, Intra M, Minchella I, Veronesi P, Viale G, Goldhirsch A, Colleoni M. Iorfida M, et al. Among authors: balduzzi a. Breast. 2010 Apr;19(2):128-32. doi: 10.1016/j.breast.2009.12.011. Epub 2010 Feb 8. Breast. 2010. PMID: 20117001 Free article.

9

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.

Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, Goldhirsch A, Colleoni M. Balduzzi A, et al. Cancer Treat Rev. 2010 Oct;36(6):443-50. doi: 10.1016/j.ctrv.2010.02.019. Epub 2010 Mar 20. Cancer Treat Rev. 2010. PMID: 20304562 Review.

10

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.

Montagna E, Bagnardi V, Rotmensz N, Viale G, Pruneri G, Veronesi P, Cancello G, Balduzzi A, Dellapasqua S, Cardillo A, Luini A, Zurrida S, Gentilini O, Mastropasqua MG, Bottiglieri L, Iorfida M, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: balduzzi a. Breast Cancer Res Treat. 2010 Dec;124(3):689-99. doi: 10.1007/s10549-010-1027-4. Epub 2010 Jul 13. Breast Cancer Res Treat. 2010. PMID: 20625816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters